Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer.

Cancer - 1 Feb 2011

Dong Xiaoqun, Tang Hongwei, Hess Kenneth R, Abbruzzese James L, Li Donghui

Abstract excerpt

BACKGROUND: Altered glucose metabolism is the most common metabolic hallmark of malignancies. The authors tested the hypothesis that glucose metabolism gene variations affect clinical outcome in pancreatic cancer. METHODS: The authors retrospectively genotyped 26 single nucleotide polymorphisms f...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Pancreatic Ductal
Share to GCK gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Glucose

Share to Pancreatic Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 20845477
DOI: 10.1002/cncr.25612
PMCID: PMC3961843

Genes

GCK
GFPT1
GPI

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20845477-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer.PMID 20845477Read ↗

Glucose metabolism gene variants modulate the risk of pancreatic cancer.Semantic proximity Read ↗

Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.Semantic proximity Read ↗

A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival.Semantic proximity Read ↗

Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potentialSemantic proximity Read ↗

Genetic variations associated with gemcitabine treatment outcome in pancreatic cancerSemantic proximity Read ↗

Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine.Semantic proximity Read ↗

Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer.Semantic proximity Read ↗

SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival.Semantic proximity Read ↗

Glucose metabolic phenotype of pancreatic cancer.Semantic proximity Read ↗

Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic AdenocarcinomaSemantic proximity Read ↗

A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.Semantic proximity Read ↗

Expression and clinical significance of glucose transporter-1 in pancreatic cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.